These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9681146)

  • 1. Coumarin 1,4-dihydropyridine derivatives.
    Valenti P; Rampa A; Budriesi R; Bisi A; Chiarini A
    Bioorg Med Chem; 1998 Jun; 6(6):803-10. PubMed ID: 9681146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
    Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
    Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,4-Dihydropyridines bearing a pharmacophoric fragment of lidoflazine.
    Chiarini A; Rampa A; Budriesi R; Bisi A; Fabbri G; Valenti P
    Bioorg Med Chem; 1996 Oct; 4(10):1629-35. PubMed ID: 8931932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
    Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
    Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone.
    Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P
    Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological profile of some chloroxanthone-1, 4-dihydropyridine derivatives.
    Bisi A; Budriesi R; Rampa A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Sep; 46(9):848-51. PubMed ID: 8876931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorenone and benzophenone 1,4-dihydropyridine derivatives with cardiodepressant activity.
    Rampa A; Budriesi R; Bisi A; Chiarini A; Valenti P
    Arzneimittelforschung; 1992 Nov; 42(11):1284-7. PubMed ID: 1492840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives.
    Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
    J Med Chem; 1989 Oct; 32(10):2381-8. PubMed ID: 2795609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long acting dihydropyridine calcium antagonists. 2. 2-[2-Aminoheterocycloethoxy]methyl derivatives.
    Arrowsmith JE; Campbell SF; Cross PE; Burges RA; Gardiner DG
    J Med Chem; 1989 Mar; 32(3):562-8. PubMed ID: 2918502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
    Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
    Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect.
    Rampa A; Chiarini A; Bisi A; Budriesi R; Valenti P
    Arzneimittelforschung; 1991 Jul; 41(7):705-9. PubMed ID: 1772458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
    Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
    J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation.
    Tasso B; Budriesi R; Vazzana I; Ioan P; Micucci M; Novelli F; Tonelli M; Sparatore A; Chiarini A; Sparatore F
    J Med Chem; 2010 Jun; 53(12):4668-77. PubMed ID: 20509610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivative.
    Budriesi R; Aicardi G; Campana G; Spampinato S; Zaza A; Bisi A; Rampa A; Valenti P; Chiarini A
    Eur J Pharmacol; 1998 Oct; 359(2-3):161-70. PubMed ID: 9832387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring.
    Rampa A; Budriesi R; Bisi A; Fabbri G; Barili PL; Chiarini A; Valenti P
    Arzneimittelforschung; 1995 Sep; 45(9):957-62. PubMed ID: 7488312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
    Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
    Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine.
    Alajarin R; Vaquero JJ; Alvarez-Builla J; Pastor M; Sunkel C; Fau de Casa-Juana M; Priego J; Statkow PR; Sanz-Aparicio J; Fonseca I
    J Med Chem; 1995 Jul; 38(15):2830-41. PubMed ID: 7636844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
    Anana RD; Ng H; Howlett SE; Knaus EE
    Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative inotropic and chronotropic activity of calcium channel ligands possessing a xanthone 1,4-dihydropyridine backbone.
    Chiarini A; Rampa A; Bisi A; Budriesi R; Valenti P
    Arzneimittelforschung; 1992 Jun; 42(6):797-801. PubMed ID: 1329778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.